Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis have?
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis published?
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has 2020 year in the ScholarIQ index.
What is the open-access status of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?
Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis has hybrid oa status in the ScholarIQ index.
What is the DOI of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?
The DOI for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.
What is the PMID of Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?
The PMID for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.
What is the OpenAlex record for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis?
The OpenAlex for Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis is on the source record.